Why Semiconductor Stocks AMAT, LRCX, and MU Plunged
Unlike Nvidia (NVDA) or AMD (AMD), Applied Materials (AMAT) resumed its steep downtrend after posting third-quarter results on August 15. The panic selling sent Lam Research (LRCX) and Micron (MU) lower as well.Applied recorded a $2.48 non-GAAP earnings per share. Revenue of $7.3 billion was up by 7.7% Y/Y. The outlook in Q4 is a concern. It projects $6.7 billion in revenue +/- $500 million and down by 4.9% Y/Y. Non-GAAP EPS will be 9% lower Y/Y at the midpoint. Underlying demand is strong for logic chips. Utilization on the leading edge is 100%, design wins increased, and capital expenditure is rising at cloud service providers.Unfortunately, sales are uneven. Some companies are taking longer to commit their capital. They cited tariffs, trade, and other economic uncertainties. Since Applied has a high customer concentration for “leading edge” (as mentioned on the conference call), results are uneven.Micron, a memory chip supplier, traded near a $130 high before losing nearly $10 on its share price in the last week. Still, for Q4, revenue guidance increased to $11.2 billion, up from $10.7 billion.Lam Research peaked at $108.02 last week before closing below $100. The automatic mixed securities shelf filing might pressure the stock from here.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


